President Donald Trump on Thursday announced a pair of initiatives aimed at making in vitro fertilization more affordable and accessible, marking his administration’s most significant step yet on an issue that has divided conservatives and became a key point of last year’s campaign outreach to women and families.

Speaking from the Oval Office, Trump said his administration would encourage employers to offer fertility benefits directly to their employees—similar to dental or vision coverage—and unveiled a new agreement with EMD Serono, the maker of Gonal-F, one of the most widely used fertility drugs in the United States. The company, he said, had agreed to provide “massive discounts” on its fertility medications through a government website, TrumpRx.gov, beginning next year.

“With the

See Full Page